JPRN-UMIN000004528
Recruiting
Phase 2
A phase 2 study of radio-chemotherapy for primary intracranial germ cell tumors - A phase 2 study for primary intracranial germ cell tumors
Organizing Committee for a phase 2 study of radio-chemotherapy for primary intracranial germ cell tumors0 sites210 target enrollmentDecember 15, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Organizing Committee for a phase 2 study of radio-chemotherapy for primary intracranial germ cell tumors
- Enrollment
- 210
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Previous malignancies. 2\. Major renal, bladder, infectious illnesses, interstitial pneumonitis or pulmonary fibrosis, ischemic heart diseases, liver cirrhosis, bleeding, uncontrolled DM, or psychiatric impairments which in the investigator's opinion will prevent administration or completion of the protocol therapy. 3\. Patients with known allergy to drugs used in the proposed regimens. 4\. Patients taking warfarin. 5\. patients pregnant or breast\-feeding a baby. 6\. Patients, in the investigator's opinion, cannot complete the protocol study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Treatment of primary intracranial germ cell tumorsprimary intracranial germ cell tumorsD009373JPRN-jRCTs031180223Matsutani Masao210
Active, not recruiting
Not Applicable
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study - radiotherapy for vulvar canceradvanced stage squamous cell cancer of the vulvaMedDRA version: 8.1Level: LLTClassification code 10047777Term: Vulvar cancerEUCTR2006-004052-20-NLKoningin Wilhelmina Fonds
Completed
Phase 2
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy studyvulvar cancervulvar neoplasm1003859710029903NL-OMON30199Academisch Medisch Centrum68
Completed
Phase 2
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancerJPRN-UMIN000010428West Japan Oncology Group44
Recruiting
Phase 2
Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapyesophageal cancerJPRN-UMIN000005295Department of Gastroenterological Surgery,Graduate School of medicine,Osaka University25